<?xml version="1.0"  ?><!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd"><pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xml:lang="en" article-type="research-article" dtd-version="1.4"><!--The publisher of this article does not allow downloading of the full text in XML form.--><front><journal-meta><journal-id journal-id-type="nlm-ta">Drug Alcohol Rev</journal-id><journal-id journal-id-type="iso-abbrev">Drug Alcohol Rev</journal-id><journal-id journal-id-type="pmc-domain-id">319</journal-id><journal-id journal-id-type="pmc-domain">nihpa</journal-id><journal-title-group><journal-title>Drug and alcohol review</journal-title></journal-title-group><issn pub-type="ppub">0959-5236</issn><issn pub-type="epub">1465-3362</issn><custom-meta-group><custom-meta><meta-name>pmc-is-collection-domain</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-collection-title</meta-name><meta-value>NIHPA Author Manuscripts</meta-value></custom-meta></custom-meta-group></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC11164253</article-id><article-id pub-id-type="pmcid-ver">PMC11164253.319</article-id><article-id pub-id-type="pmcaid">11164253</article-id><article-id pub-id-type="pmcaiid">11164253</article-id><article-id pub-id-type="manuscript-id">NIHMS1997547</article-id><article-id pub-id-type="pmid">37946605</article-id><article-id pub-id-type="doi">10.1111/dar.13712</article-id><article-id pub-id-type="manuscript-id-alternative">NIHMS1997547</article-id><article-id pub-id-type="manuscript-id-alternative">NIHPA1997547</article-id><article-version article-version-type="pmc-version">319</article-version><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title-group><article-title>Association Between Prescription Drug Monitoring Programs Use Mandates and Prescription Stimulants Received by Medicaid Enrollees</article-title></title-group><contrib-group><contrib contrib-type="author"><name name-style="western"><surname>Gunadi</surname><given-names initials="C">Christian</given-names></name><degrees>PhD</degrees><xref rid="A1" ref-type="aff">1</xref><xref rid="CR1" ref-type="corresp">*</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Shi1</surname><given-names initials="Y">Yuyan</given-names></name><degrees>PhD</degrees><xref rid="A1" ref-type="aff">1</xref></contrib></contrib-group><aff id="A1"><label>1</label>Herbert Wertheim School of Public Health and Human Longevity Science, University of California San Diego, La Jolla, CA, USA</aff><author-notes><fn fn-type="con" id="FN1"><p id="P1">Author contribution statement:</p><p id="P2">Each author certifies that their contribution to this work meets the standards of the International Committee of Medical Journal Editors.</p></fn><corresp id="CR1"><label>*</label>Corresponding author Christian Gunadi, PhD, 9500 Gilman Drive, La Jolla, CA 92093-0628, USA, <email>cgunadi@health.ucsd.edu</email></corresp><fn fn-type="COI-statement" id="FN2"><p id="P35">DISCLOSURES:</p><p id="P36">Conflict of Interest Disclosure: Drs. Gunadi and Shi report no conflict of interest.</p></fn></author-notes><pub-date pub-type="ppub"><month>11</month><year>2023</year></pub-date><pub-date pub-type="epub"><day>04</day><month>7</month><year>2023</year></pub-date><volume>42</volume><issue>7</issue><issue-id pub-id-type="pmc-issue-id">464577</issue-id><fpage>1658</fpage><lpage>1666</lpage><pub-history><event event-type="nihms-submitted"><date><day>26</day><month>05</month><year>2024</year></date></event><event event-type="pmc-release"><date><day>10</day><month>06</month><year>2024</year></date></event><event event-type="pmc-live"><date><day>10</day><month>06</month><year>2024</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2024-06-11 10:25:24.077"><day>11</day><month>06</month><year>2024</year></date></event></pub-history><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pmc-pdf" xlink:href="nihms-1997547.pdf"/><abstract id="ABS1"><sec id="S1"><title>Introduction:</title><p id="P3">Prescription Drug Monitoring Program (PDMP) use mandate is an important policy tool to curb opioid abuse. However, data are scarce about its efficacy on other commonly abused prescription drugs such as stimulants.</p></sec><sec id="S2"><title>Methods:</title><p id="P4">We used 2010&#8211;2020 state-level secondary data from Medicaid State Drug Utilization Data and quasi-experimental difference-in-differences research design to estimate the association between PDMP use mandates and population-adjusted stimulants (amphetamine and methylphenidate) prescribing outcomes: 1) number of prescriptions filled; 2) total amount reimbursed in U.S. dollars. To account for heterogeneity in the mandate across U.S. states, two policy variables were considered: limited and expansive. Limited PDMP use mandate requires prescribers or dispensers to check PDMP only when prescribing/dispensing opioids or benzodiazepine, while expansive PDMP use mandate is non-specific to opioid/benzodiazepine and requires prescribers or dispensers to check PDMP when prescribing/dispensing targeted controlled substances in Drug Enforcement Agency Schedule II-V. The sample included 49 U.S. states and the District of Columbia. Nevada was excluded since it implemented the PDMP mandate before the period of analysis.</p></sec><sec id="S3"><title>Results:</title><p id="P5">The state-wide implementation of the PDMP use mandate, either limited or expansive, was not associated with the number of prescriptions filled or the total amount reimbursed in U.S. dollars for stimulants among Medicaid enrollees.</p></sec><sec id="S4"><title>Discussion and Conclusion:</title><p id="P6">There was no evidence for the associations between PDMP use mandates and stimulant prescribing among Medicaid enrollees. Future works are encouraged to replicate the study in other populations and with longer post-period analysis when the impact of the mandates might be more successfully materialized.</p></sec></abstract><kwd-group><kwd>Health Policy/Regulation</kwd><kwd>Substance Abuse</kwd><kwd>Chemical Dependency</kwd><kwd>Observational Data/Quasi-Experiments</kwd></kwd-group><custom-meta-group><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>yes</meta-value></custom-meta></custom-meta-group></article-meta></front></article></pmc-articleset>